Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9023
Cytogenetic and Flow Cytometric Analysis of Solid Tumors: Renal Cell Carcinoma: A Companion Study to SWOG-8949
Research Committee(s)
Genitourinary Cancer
Activated
07-01-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9307
Extended Administration of Oral Etoposide And Oral Cyclophosphamide for the Treatment of Poor Prognosis Extensive Disease Small Cell Lung Cancer, Phase II Pilot
Research Committee(s)
Lung Cancer
Activated
07-01-1993
Closed
06-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9106
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
SWOG-9213
A Phase II Evaluation of Fazarabine for Patients with "Poor Prognosis” Extensive Stage Small Cell Lung Cancer
Activated
06-15-1993
Closed
06-15-1994
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9157
Trial of All Trans-Retinoic Acid in Hepatoma, Phase II.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-1993
Closed
08-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9230
Evaluation of Interleukin-4 (IL-4) in Disseminated Renal Cell Adenocarcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
06-01-1993
Closed
05-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9248
A Phase II Trial of Paclitaxel (Taxol ®) in Patients with Metastatic Refractory Carcinoma of the Breast
Research Committee(s)
Breast Cancer
Activated
06-01-1993
Closed
02-01-1994
Closed
Phase
Accrual
94%
Published
SWOG Clinical Trial Number
SWOG-9242
Evaluation of Taxotere in Small Cell Lung Carcinoma, Phase II
Research Committee(s)
Lung Cancer
Activated
05-01-1993
Closed
01-15-1997
Closed
Phase
Accrual
23%
SWOG Clinical Trial Number
SWOG-9120
Investigation of G-CSF and Trans-Retinoic Acid in the Treatment of Myelodysplastic Syndrome, Phase I
Activated
04-01-1993
Closed
07-01-1995
Closed
Phase
SWOG Clinical Trial Number
SWOG-9245
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease, Ancillary
Research Committee(s)
Lymphoma
Activated
03-15-1993
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
SWOG-9210
A Phase III Randomized Trial of Combination Therapy for Multiple Myeloma Comparison of (1) VAD-P to VAD-P/Quinine for Induction; (2) Randomization of Prednisone Dose Intensity For Remission Maintenance
Research Committee(s)
Myeloma
Activated
03-15-1993
Closed
09-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9237
Evaluation of Topotecan in Resistant and Relapsing Multiple Myeloma, Phase II
Research Committee(s)
Myeloma
Activated
03-01-1993
Closed
02-15-1995
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
SWOG-9246
A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma
Activated
03-01-1993
Closed
12-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9126
A Controlled Trial of Cyclosporine as a Chemotherapy- Resistance Modifier in High Risk Acute Myeloid Leukemia, Phase III
Research Committee(s)
Leukemia
Activated
03-01-1993
Closed
03-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9229
Concurrent Cisplatin, Prolonged Oral Etoposide and Vincristine Plus Chest and Brain Irradiation for Limited Small Cell Lung Carcinoma, Phase II Pilot
Research Committee(s)
Lung Cancer
Activated
02-15-1993
Closed
05-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9041
Chemoprevention of Recurrent Adenomas and Second Primary Colorectal Carcinoma, A Phase III Pilot Study
Activated
02-01-1993
Closed
04-15-1999
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9218
Measurement of Biologic and Molecular Tumor Markers in Patients with High Grade Primary Brain Tumors Treated on SWOG-8737
Research Committee(s)
Brain Cancer
Activated
01-15-1993
Closed
04-01-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9240
A Phase II Trial of CVAD for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
01-15-1993
Closed
02-01-1994
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9100
A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma
Activated
01-15-1993
Closed
08-01-1994
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
SWOG-9207
Phase II Trial of Edatrexate Plus Carboplatin in Metastatic Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
01-01-1993
Closed
06-01-1995